title: Evaluation of the safety and efficacy of gadoteridol injection (a low osmolal magnetic resonance contrast agent). Clinical trials report.
authors.affiliation: Squibb Diagnostics, Princeton, New Jersey.
authors.forename: D
authors.initials: D
authors.lastname: DeSimone
authors.forename: M
authors.initials: M
authors.lastname: Morris
authors.forename: C
authors.initials: C
authors.lastname: Rhoda
authors.forename: T
authors.initials: T
authors.lastname: Lucas
authors.forename: J
authors.initials: J
authors.lastname: Zielonka
authors.forename: A
authors.initials: A
authors.lastname: Olukotun
authors.forename: M
authors.initials: M
authors.lastname: Carvlin
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D006571:Heterocyclic Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D009994:Osmolar Concentration; D013125:Spinal Neoplasms / Q000175:diagnosis
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium